As of 11:13:51 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-74,244.00
-92,078.00
-78,730.00
-60,087.00
-5,487.00
Investing Cash Flow
13,536.00
43,461.00
128,707.00
-4,751.00
-20,275.00
Financing Cash Flow
34,486.00
38,151.00
311.00
46,608.00
39,140.00
End Cash Position
38,561.00
53,683.00
64,149.00
13,861.00
32,091.00
Capital Expenditure
-3,098.00
-2,375.00
-43.00
-39.00
-349.00
Issuance of Capital Stock
--
1,117.00
--
44,969.00
38,449.00
Free Cash Flow
-77,342.00
-94,453.00
-78,773.00
-60,126.00
-5,836.00
12/31/2020 - 1/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COEP Coeptis Therapeutics Holdings, Inc.
5.14
-6.55%
MRNS Marinus Pharmaceuticals, Inc.
0.5347
-0.07%
VSTM Verastem, Inc.
6.45
+24.76%
REVB Revelation Biosciences, Inc.
0.6410
+38.84%
FGEN FibroGen, Inc.
0.5149
-2.76%
RAPT RAPT Therapeutics, Inc.
1.7400
+10.13%
VINC Vincerx Pharma, Inc.
0.2407
-8.43%
KPTI Karyopharm Therapeutics Inc.
0.7606
+12.46%
NLSP NLS Pharmaceutics AG
2.2401
+6.17%
SPRC SciSparc Ltd.
0.3808
+5.78%